MIAMI - Pulse Biosciences, Inc. (NASDAQ: NASDAQ:PLSE), a bioelectric medicine company focusing on its proprietary CellFX nanosecond Pulsed Field Ablation (nsPFA) technology, has announced the ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...
She took 28 bioelectric recordings from plants used in cancer treatment. This included Madagascan periwinkle, which has yielded compounds used to treat Hodgkin’s lymphoma and some types of ...